Tretinoin
Also known as: ATRA Retinoic Acid All-trans retinoic acid
Active ingredient description
Tretinoin decreases cohesiveness of follicular epithelial cells resulting in decreased microcomedone formation. Additionally, tretinoin stimulates mitotic activity and increased turnover of follicular epithelial cells, causing extrusion of the comedones.
Medicine classification
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
Product monographs
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
Medicines
Tretinoin is the active ingredient of these drugs:
Turkey
Hong Kong
Hong Kong
Estonia South Africa
Turkey
United States
United States
United States
Finland
Ecuador
Estonia
Germany
South Africa
France
South Africa
Estonia France Hong Kong
Tunisia
Spain
United States
United States
France Singapore South Africa
South Africa
Canada Estonia Mexico United States
Estonia Spain
New Zealand Singapore
Canada Singapore
Austria Brazil Canada Estonia Finland
Brazil Hong Kong
Brazil
Tretinoin is also found within below combination drugs:
ACNATAC , ACTIN-NEO , AKNEMYCIN PLUS , ATREDERM , BALISA VAS , BETARRETIN H , BIACNA , CLINDATRE , EFASOL , ERITRETIN , ERYLIK , HORMOSKIN , OSKIN , SUAVICID , TRECLIN , TRECLINAC , TRI-LUMA , TRINULOX , UREOTOP AND VAS , VELTIN , VITACID ACNE , VITACID PLUS , ZANEA , ZIANA